Prostate-specific antigen following radiation therapy

被引:0
|
作者
机构
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] THE EFFECT OF PELVIC RADIATION-THERAPY ON SERUM LEVELS OF PROSTATE-SPECIFIC ANTIGEN
    WILLETT, CG
    ZIETMAN, AL
    SHIPLEY, WU
    COEN, JJ
    JOURNAL OF UROLOGY, 1994, 151 (06): : 1579 - 1581
  • [22] Western blotting analysis of antibodies to prostate-specific antigen: Specificities for prostate-specific antigen and prostate-specific antigen fragments
    Wang, TJ
    Linton, HJ
    Sokoloff, RL
    Grauer, LS
    Rittenhouse, HG
    Wolfert, RL
    TUMOR BIOLOGY, 1999, 20 : 79 - 85
  • [23] EFFECT OF EXTERNAL BEAM RADIATION-THERAPY ON SERUM PROSTATE-SPECIFIC ANTIGEN
    CHODAK, GW
    SUTTON, H
    NEUMANN, J
    FARAH, R
    BLIX, G
    UROLOGY, 1990, 35 (04) : 288 - 294
  • [24] Prostate-specific antigen decline during salvage radiation therapy following prostatectomy is associated with reduced biochemical failure
    Kabarriti, Rafi
    Ohri, Nitin
    Hannan, Raquibul
    Tishbi, Nima
    Baliga, Sujith
    McGovern, Kevin P.
    Mourad, Waleed F.
    Ghavamian, Reza
    Kalnicki, Shalom
    Guha, Chandan
    Garg, Madhur K.
    PRACTICAL RADIATION ONCOLOGY, 2014, 4 (06) : 409 - 414
  • [25] Time to detectable metastatic disease in patients with rising prostate-specific antigen values following surgery or radiation therapy
    Slovin, SF
    Wilton, AS
    Heller, G
    Scher, HI
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8669 - 8673
  • [26] PATIENT-EVALUATION IF PROSTATE-SPECIFIC ANTIGEN BECOMES ELEVATED FOLLOWING RADICAL PROSTATECTOMY OR RADIATION-THERAPY
    FERGUSON, JK
    OESTERLING, JE
    UROLOGIC CLINICS OF NORTH AMERICA, 1994, 21 (04) : 677 - 685
  • [27] Prostate-specific antigen velocity and repeated measures of prostate-specific antigen
    Carter, HB
    Pearson, JD
    UROLOGIC CLINICS OF NORTH AMERICA, 1997, 24 (02) : 333 - &
  • [28] Prostate-specific antigen nadir and testosterone level at prostate-specific antigen failure following radiation and androgen suppression therapy for unfavorable-risk prostate cancer and the risk of all-cause and prostate cancer-specific mortality
    Bitterman, Danielle S.
    Chen, Ming-Hui
    Wu, Jing
    Renshaw, Andrew A.
    Loffredo, Marian
    Kantoff, Philip W.
    Small, Eric J.
    D'Amico, Anthony V.
    CANCER, 2021, 127 (15) : 2623 - 2630
  • [29] CHANGES IN PROSTATE-SPECIFIC ANTIGEN AND PERCENT FREE PROSTATE-SPECIFIC ANTIGEN IN MEN TREATED WITH TESTOSTERONE REPLACEMENT THERAPY
    Morgentaler, A.
    Kaufman, J. M.
    Denes, B. S.
    Miller, M. G.
    Benesh, J. A.
    Kan-Dobrosky, N.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 207 - 208
  • [30] Prostate-specific membrane antigen radioligand therapy of prostate cancer
    Beheshti, Mohsen
    Heinzel, Alexander
    von Mallek, Dirk
    Filss, Christian
    Mottaghy, Felix M.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 63 (01): : 29 - 36